Singapore and the tobacco pandemic

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 5, 2008, Pages 363-364

  Lim, Tow Keang ^a  

^a Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE GUM; VARENICLINE;

BEHAVIOR THERAPY; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COUNSELING; EDITORIAL; HEALTH SURVEY; HUMAN; MORTALITY; PANDEMIC; PHYSICIAN ATTITUDE; SINGAPORE; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; WORLD HEALTH ORGANIZATION;

EID: 45249114883     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. World Health Organization, Report on the Global Tobacco Epidemic 2008. Available at: http://www.who.int/tobacco/mpower/en/index.html. Accessed 29 March 2008.
2. Health Promotion Board. National Smoking Control Program Available at: http://www.hpb.gov.sg/hpb/default.asp?pg_id=1030. Accessed 29 March 2008.
3. World Health Organization. World No Tobacco Day 2008. Available at: http://www.who.int/tobacco/wntd/2008/en/index.html. Accessed 29 March 2008.
4. Ng EH. Address by Dr Ng Eng Hen, Minister for Manpower and Second Minister for Defence at the Fourth Ministerial Consultation on Overseas Employment and Contractual Labour for Countries of Origin in Asia, 22 January 2008, Emirates Palace, Abu Dhabi. Available at: http:// www.mom.gov.sg/publish/ momportal/en/press_room/mom_speeches/ 2008/20080122-Speech_Emirates.html. Accessed 21 April 2008.
5. Connett JE, Kusek JW, Bailey WC, O'Hara P, Wu M. Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials 1993; 14(2 Suppl):3S-19S.
6. Murray RP, Connett JE, Rand CS, Pan W, Anthonisen NR. Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years. Prev Med 2002;35:314-9.
7. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-9.
8. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med l997;337:l 195-202.
9. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams K.E, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296: 56-63.
10. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004(4):CD000165.
11. Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a priming effect. Arch Fam Med 2000;9:426-33.
12. Thorndike AN, Regan S, Rigotti NA. The treatment of smoking by US physicians during ambulatory visits: 1994-2003. Am J Public Health 2007;97:1878-83.